Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

TECHNICIAN - BCPA: Direct Oral Anticoagulants in Patients with Severe Obesity


Date: Apr 28, 2021 07:00 PM - 07:45 PM

Location: UIW Feik School of Pharmacy, 703 E. Hildebrand, San Antonio, TX, 78212

CE Hours

1.00

CE Units

0.100

Registration closes on Jun 09, 2021 11:55 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacy Technicians

Accreditation(s)

 
 
 
 
 
Accreditation Council for Pharmacy Education
The University of the Incarnate Word Feik School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
 
 
 
 

Joint Provider(s)

Bexar County Pharmacy Association (BCPA) and Central Texas Society of Health-System Pharmacists (CTSHP)

Requirements for CE Credit

  • The participant will only receive credit for programs after receiving a 70% on a post-test and an evaluation form is completed and submitted. 
  • The entire session must be attended to receive credit. No partial credit will be given. 
  • Certificates will not be mailed. Contact hours will be uploaded to NABP's CPE Monitor after successful completion of post-test and program evaluation. 
  • To receive credit, participant profiles must contain a valid NABP e-profile ID number and month/date of birth. 
  • All requirements to receive credit must be completed within six weeks of participation in the CPE program. Failure to complete requirements within the six-week window will result in no credit awarded to the participant. 

Please choose a Fee Type from the Drop Down Menu Below:
I am a
 

 

Registration closes on Jun 09, 2021 at 11:55 PM

Registration Closed  

Upon completion of this activity, participants will be able to:
  1. Identify current treatment recommendations for venous thromboembolism (VTE) and atrial fibrillation (AF).
  2. Recall the 2016 guidance from the International Society of Thrombosis and Haemostasis (ISTH) on direct oral anticoagulants (DOACs) in patients with severe obesity.
  3. List the strengths and limitations of current literature for the use of DOACs in patients with severe obesity and with AF or VTE.
 
 

Speaker(s)/Author(s)

Haley Tierce

Activity Number

0445-9999-21-009-L01-T
Date: 04/28/21
Time: 07:00 PM - 07:45 PM

CE Hours

1.00

Location

https://uiw.zoom.us/j/91285082333
Registration Closed